← All trials
NCT04713475
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 17, 2021
- Primary completion
- Feb 28, 2026
- Completion date
- Feb 28, 2029
- First posted
- Jan 19, 2021
- Last posted
- Oct 8, 2021
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Passage Bio, Inc.Lead sponsor
- Passage Bio, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.